Director/PDMR Shareholding

RNS Number : 2805A

AstraZeneca PLC

28 March 2012

 



Transaction by Persons Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

On 27 March 2012, the interest of the following individuals, who are all persons discharging managerial responsibilities, in AstraZeneca PLC ordinary shares, changed as detailed below.  The change in interest relates to the vesting of previously announced awards made in March 2009 under the AstraZeneca Performance Share Plan, whereby, following the application of performance measures specified at the time of grant, the individuals listed, with the exception of Katarina Ageborg, have now become beneficially entitled to 78% of the shares originally awarded.  In accordance with the plan rules, any unvested part of the award has immediately and irrevocably lapsed.  The award made to Katarina Ageborg, who was not a member of AstraZeneca's Senior Executive Team at the time of the award, was subject to different performance conditions, the outcome of which resulted in a vesting percentage of 101.5%. In each case, sufficient vested shares were withheld to cover certain tax obligations arising on the vesting.  The interests of Lynn Tetrault and Tony Zook are in the Company's American Depositary Shares (ADSs).  One ADS equals one ordinary share.

Name	Shares awarded	Shares vested	Shares withheld	Net shares received	Market price on vesting
Katarina Ageborg	4,359	4,424	0	4,424	2854p
Jeff Pott	23,026	17,960	9,509	8,451	2854p
David Smith	25,000	19,500	6,808	12,692	2854p
Lynn Tetrault	55,444	43,246	17,312	25,934	$45.65
Tony Zook	85,229	66,478	28,220	38,258	$45.65

A C N Kemp

Company Secretary

28 March 2012

 

END

 

 

RDSUWOORUSAOUAR